Literature DB >> 18172014

Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding?

Brian S Schwartz, Penny D Ngo, B Joseph Guglielmo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18172014     DOI： 10.1345/aph.1k548

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  11 in total

1.  Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.

Authors:  Jose M Munita; Diana Panesso; Lorena Diaz; Truc T Tran; Jinnethe Reyes; Audrey Wanger; Barbara E Murray; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Enterococcal endocarditis: can we win the war?

Authors:  Jose M Munita; Cesar A Arias; Barbara E Murray
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.

Authors:  J A McKinnell; M Patel; R M Shirley; D F Kunz; S A Moser; J W Baddley
Journal:  Epidemiol Infect       Date:  2010-11-15       Impact factor: 2.451

4.  Establishment of a new methicillin resistant Staphylococcus aureus animal model of osteomyelitis.

Authors:  Lars Helbig; Hans Georg Simank; Helga Lorenz; Cornelia Putz; Christoph Wölfl; Arnold J Suda; Arash Moghaddam; Gerhard Schmidmaier; Thorsten Guehring
Journal:  Int Orthop       Date:  2013-10-30       Impact factor: 3.075

Review 5.  Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci.

Authors:  Jose M Munita; Barbara E Murray; Cesar A Arias
Journal:  Int J Antimicrob Agents       Date:  2014-09-02       Impact factor: 5.283

6.  Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections.

Authors:  Cesar A Arias; Rodrigo E Mendes; Matthew G Stilwell; Ronald N Jones; Barbara E Murray
Journal:  Clin Infect Dis       Date:  2012-04       Impact factor: 9.079

Review 7.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  A potential role for daptomycin in enterococcal infections: what is the evidence?

Authors:  Rafael Cantón; Patricia Ruiz-Garbajosa; Ricardo L Chaves; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2010-04-02       Impact factor: 5.790

9.  What's New in the Treatment of Enterococcal Endocarditis?

Authors:  Masayuki Nigo; Jose M Munita; Cesar A Arias; Barbara E Murray
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

10.  A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis.

Authors:  Jose M Munita; Truc T Tran; Lorena Diaz; Diana Panesso; Jinnethe Reyes; Barbara E Murray; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.